← Back

$ Value

$0

Shares

264,518

Price

$0

Filed

Jul 30

Insider

Name

Martha Geoffrey

Title

Chairman and CEO

CIK

0001560409

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-28

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

264,518

Footnotes

Represents restricted stock units that vest 100% on the third anniversary of the date of grant. | Includes 1,693 shares acquired through dividend reinvestment since the last report filed by the reporting person. | Each performance share unit represents a contingent right to receive one share of Medtronic common stock. | Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. | The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 93,781 shares will be issued. If maximum performance metrics are achieved, 187,562 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. | These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Filing Info

Accession No.

0001613103-25-000113

Form Type

4

Issuer CIK

0001613103

Martha Geoffrey's History

Date Ticker Type Value
2026-02-12 NEE A $0
2025-12-15 MDT F $156K
2025-08-01 MDT M $0
2025-08-01 MDT F $2.4M
2025-08-01 MDT F $1.2M
2025-08-01 MDT M $3.2M
2025-08-01 MDT F $3.4M
2025-08-01 MDT M $0
2025-08-01 MDT M $0
2025-07-28 MDT A $0

Other Insiders at MDT (90d)

Insider Bought Sold Last
KIIL HARRY SKIP
EVP & President Cardiovascular
$5.1M 2026-02-19
Pieton Thierry
EVP & Chief Financial Officer
2026-03-03
Blomquist Denise L.
Chief Accounting Officer
2026-02-20